[Retracted] Scolopendra subspinipes mutilans L. Koch Ameliorates Rheumatic Heart Disease by Affecting Relative Percentages of CD4⁺CD25⁺FoxP3 Treg and CD4⁺IL17 T Cells

Table 1

Clinical characteristics of all participants.

	SSLK group (N=40)	Control group (N=40)	t/χ2 values	P values
Age, (years)	47.85 ± 9.95	45.20 ± 9.99	0.984	0.324
Female, n (%)	31(77.5)	28(70)	0.581	0.446
BMI, kg/m^2	23.92 ± 2.26	23.32 ± 2.47	0.157	0.873
Smoking, n (%)	8 (20)	4 (10)	1.569	0.210
Diabetes, n (%)	5 (12.5)	6(15)	0.105	0.745
Hypertension, n (%)	32(78)	33(82.5)	0.082	0.775
Ongoing treatment
Digoxin, n (%)	10(25)	8(20)	0.287	0.592
Aspirin, n (%)	22(55)	23(57.5)	0.051	0.822
NYHA classification
II, n (%)	34(85)	35(87.5)	0.626	0.731
III, n (%)	6(15)	8(20)
AF, n (%)	38(95)	33(82.5)
Mitral stenosis,
Moderate, n (%)	20(50)	23(57.5)	0.188	0.664
Severe, n (%)	15(37.5)	14(35)
Aortic stenosis,
Moderate, n (%)	3(7.5)	4(10)
Severe, n (%)	2(5)	3(7.5)
Tricuspid incompetence
Mild, n (%)	28(70)	29(72.5)	0.583	0.747
Moderate, n (%)	6(15)	8(20)
Severe, n (%)	2(5)	1(2.5)
Plasma measurements,
Triglycerides,	2.16 ± 1.24	1.94 ± 1.77	0.763	0.482
Total cholesterol (mmol/L),	5.33 ± 1.36	4.67 ± 1.41	1.639	0.163
LDL-C (mmol/L),	3.31 ± 0.89	3.46 ± 0.99	0.652	0.561
HDL-C (mmol/L),	1.59 ± 0.67	1.68 ± 0.39	0.758	0.478

Note: SSLK, Scolopendra subspinipes mutilans L. Koch. BMI, body mass index. NYHA, the New York Heart Association; AF, atrial fibrillation; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.